Sangamo Biosciences reported $-48700000 in EBIT for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acceleron Pharma XLRN:US $ -63662000 59K
Alnylam Pharmaceuticals ALNY:US $ -146160000 40.09M
Amgen AMGN:US $ 2333M 204M
Avrobio Inc AVRO:US $ -31375000 4.49M
Bayer BAYN:GR 1.64B 1.42B
Biocryst Pharmaceuticals BCRX:US $ -29582000 21.8M
Biogen BIIB:US $ 1030.1M 12.3M
Biomarin Pharmaceutical BMRN:US $ 13.86M 13.56M
Bluebird Bio BLUE:US $ -240791000 9.95M
Gilead Sciences GILD:US $ 2262M 639M
GlaxoSmithKline GSK:LN 1.96B 281M
Intercept Pharmaceuticals ICPT:US $ 511K 29.7M
IONIS PHARMACEUT IONS:US $ -72969000 19M
Johnson & Johnson JNJ:US $ 6901M 94M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Merk MRK:US $ 3930M 332M
Novartis NOVN:VX 3.4B 415M
Omeros OMER:US $ -24016000 6.6M
Pfizer PFE:US $ 6662M 905M
Sangamo Biosciences SGMO:US $ -48700000 2.4M
Sarepta Therapeutics SRPT:US $ -167574000 25.71M
Ultragenyx Pharmaceutical RARE:US $ -82776000 23.79M
Vertex Pharmaceuticals VRTX:US $ -36.36M 920.29M
Ziopharm Oncology ZIOP:US $ -22639000 1.08M